We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

ELITechGroup

Offers a range of products for in vitro diagnostics in clinical chemistry, hemostasis, microbiology, immunology, and ... read more Featured Products: More products

Download Mobile App





Automated Molecular Diagnostics System Presented at AACC 2015

By LabMedica International staff writers
Posted on 30 Jul 2015
A fully automated molecular diagnostics system has been presented that automatically performs nucleic acid extraction and purification from a large panel of biological specimens, amplification and detection of the nucleic acid extracted by reverse transcription polymerase chain reaction (RT-PCR), and result analysis. More...


The system automatically performs all the steps of molecular diagnostics including extraction, amplification and result analysis with one to 12 samples being processed with greater flexibility. The system offers the possibility to potentially mix any kind of sample matrices within the same run and perform multiple and independent PCR even with completely diverse thermal profiles simply on demand. In addition, each of the 12 real-time PCR thermal cyclers is equipped with six-optical channels, supplemented when appropriate with melt-curve analysis to provide extended multiplexing capability.

The system called of ELITe InGenius (ELITechGroup; Puteaux, France) in collaboration with Precision System Science, Co., Ltd. (PSS; Matsudo, Japan) is on the verge of receiving the upcoming Conformité Européenne – In Vitro Diagnostics (CE-IVD) marking for IVD applications in Europe and the upcoming availability of the instrument as Laboratory Use Equipment in the USA. The system is enabled with a unique real-time PCR menu based on ELITechGroup’s proven MGB technology, providing a rapid introduction of CE-IVD infectious disease menu for transplant monitoring and Healthcare Acquired Infections, also known as nosocomial infections. The versatile system can also be used as an open platform running laboratory developed tests or other tests of interest.

Christoph Gauer, CEO of ELITechGroup, said, “The launch of the ELITe InGenius system is a major step forward in our strategy to offer global solutions for Molecular Diagnostics. In partnership with PSS, we have taken advantage of decades of development expertise in molecular diagnostics chemistry and our proprietary real-time PCR menu to develop and validate a complete sample-to-result solution for infectious disease testing. The ELITe InGenius is a real breakthrough for molecular diagnostics. It combines unique capabilities not available on other sample-to-result systems, like universal extraction, storage of extracted nucleic acid and multiple and independently controlled RT-PCR with multiplexing capabilities, offering to the laboratory an unprecedented flexibility and assay menu possibility.” The ELITe InGenius system was shown at booth 2525 at the American Association of Clinical Chemistry (AACC) meeting held July 28–30, 2015, in Atlanta (GA, USA).

Related Links:

ELITechGroup 
Precision System Science 
American Association of Clinical Chemistry  



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Unlike conventional molecular methods, VedaBio\'s CRISPR-based technology detects targets without requiring amplification (Photo courtesy of Veda Bio)

Target-Amplification-Free CRISPR Platform Demonstrates Molecular Detection in Under 10 Minutes

Molecular testing plays an important role in clinical diagnostics, but conventional workflows often require time-consuming procedures and specialized equipment, limiting their use outside centralized laboratories.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.